Tocilizumab in Active Moderate-severe Graves' Orbitopathy

Clinical trial NCT04876534 · UNKNOWN

Trial details

NCT number: NCT04876534
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Graves Ophthalmopathy

Start date: 2019-12-18
Primary completion: 2022-12-18
Enrollment: 64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.